PROFILE OF LEPROSY IN CHILDREN FROM 2014-2018 IN DR. SOETOMO GENERAL HOSPITAL SURABAYA
DOI:
https://doi.org/10.56127/jukeke.v1i3.291Keywords:
Coping Mechanism, Type 2 Diabetes MellitusAbstract
Type 2 Diabetes Melitus is a metabolic disorder that is marked by the rise in blood sugar due to a decrease in insulin secretation by pancreatic beta cells and insulin function ordisorders (insulin resistance). Risk factors of diabetes mellitus type 2, namely age, gender, obesity, hypertension, genetics, diet, smoking, alcohol, lack of activity. Patients with Diabetes Melitus are required to implement a complex management disease such as nutritional therapy, physical exercise, glucose controlling, and pharmalogical therapy. Diabetes melitus can cause complications and symptoms that interferes activities, the implications of Diabetes Melitus be a stressor that cause stress, stressor can be controlled by coping mechanism. Mechanism coping is an active process in which the use of resources from the private and develop new behavior that aims to grow the strength of an individual, even an emergency reduce the impact of stress in life, disability incurred. Coping mechanism is adaptive and maladaptive. This aims study to explore coping strategies of patients with type 2 diabetes melitus in internal medice polyclinic Cipto Mangunkusumo Hospital, Jakarta. This study used quantitative description. Research result shows that patient who use adaptive coping 38 people (73%), whereas the use coping maladaptive 14 people (27%), then it can be concluded that diabetes mellitus patients more coping mechanisme malaadaptive.
References
Aisyah, I. And Agusni, I., 2018. Penelitian Retrospektif: Gambaran Pasien Baru Kusta. Berkala Ilmu Kesehatan Kulit Dan Kelamin – Periodical Of Dermatology And Venereology, 30(1), Pp.40-47.
Bandeira, S., Pires, C. And Quaresma, J., 2019. Leprosy Reactions In Childhood: A Prospective Cohort Study In The Brazilian Amazon. Infection And Drug Resistance, 12, Pp.3249-3257.
Bhandari, J., Awais, M., Robbins, B. And Gupta, V., 2022. Leprosy. [Online] Ncbi.Nlm.Nih.Gov. Available At: [Accessed 13 February 2022].
Bhat, R. And Prakash, C., 2012. Leprosy: An Overview Of Pathophysiology. Interdisciplinary Perspectives On Infectious Diseases, 2012, Pp.1-6.
Coppola, M., Van Den Eeden, S., Robbins, N., Wilson, L., Franken, K., Adams, L., Gillis, T., Ottenhoff, T. And Geluk, A., 2018. Vaccines For Leprosy And Tuberculosis: Opportunities For Shared Research, Development, And Application. Frontiers In Immunology, 9.
Cruz, R., Bührer-Sékula, S., Penna, M., Penna, G. And Talhari, S., 2017. Leprosy: Current Situation, Clinical And Laboratory Aspects, Treatment History And Perspective Of The Uniform Multidrug Therapy For All Patients. Anais Brasileiros De Dermatologia, 92(6), Pp.761-773.
Dinas Kesehatan Provinsi Jawa Timur, 2020. Profil Kesehatan Provinsi Jawa Timur Tahun 2019. Surabaya: Dinas Kesehatan Provinsi Jawa Timur.
Duthie, M., Pena, M., Ebenezer, G., Gillis, T., Sharma, R., Cunningham, K., Polydefkis, M., Maeda, Y., Makino, M., Truman, R. And Reed, S., 2018. Author Correction: Lepvax, A Defined Subunit Vaccine That Provides Effective Pre-Exposure And Post-Exposure Prophylaxis Of M. Leprae Infection. Npj Vaccines, 3(1).
Ismudjito, A., 2020. Penyakit Kusta : Pencegahan, Penanganan, Perawatan & Pengobatan. 1st Ed. Yogyakarta: Rapha Publishing.
Gunawan, H., Kamilia, A., Menaldi, S., Marissa, M., Prakoeswa, C., Alinda, M., Widasmara, D., Basuki, S., Anum, Q., Ariani, T., Mamuaja, E. And Rusyati, L., 2021. Characteristics Of Grade 2 Disability In Indonesian Children With Leprosy: A Five-Year Multicenter Retrospective Study. Clinical, Cosmetic And Investigational Dermatology, Volume 14, Pp.1149-1153.
Kementerian Kesehatan Republik Indonesia, 2018. Hapuskan Stigma Dan Diskriminasi Terhadap Kusta. Jakarta: Infodatin Pusat Data Dan Informasi Kementerian Kesehatan RI.
Kementerian Kesehatan Republik Indonesia, 2018. Profil Kesehatan Indonesia Tahun 2017. Jakarta: Kementerian Kesehatan Republik Indonesia.
Kumar, B. And Narang, T., 2019. Leprosy In Children. Indian Journal Of Paediatric Dermatology, 20(1), P.12.
Lastória, J. And Abreu, M., 2014. Leprosy: Review Of The Epidemiological, Clinical, And Etiopathogenic Aspects - Part 1. Anais Brasileiros De Dermatologia, 89(2), Pp.205-218.
Menteri Kesehatan Republik Indonesia, 2019. Peraturan Menteri Kesehatan Republik Indonesia Nomer 11 Tahun 2019 Tentang Penanggulangan Kusta. Jakarta: Menteri Kesehatan Republik Indonesia.
Oktaria, S., Hurif, N., Naim, W., Thio, H., Nijsten, T. And Richardus, J., 2018. Dietary Diversity And Poverty As Risk Factors For Leprosy In Indonesia: A Case-Control Study. PLOS Neglected Tropical Diseases, 12(3), P.E0006317.
Oktavian, A., Arisanti, Y., Tanjung, R. And Mirino, Y., 2018. Faktor Risiko Potensial Reaksi Kusta Pada Etnis Asli Di Dua Kantong Kusta – Papua. Buletin Penelitian Kesehatan, 46(4).
Oliveira, M. And Diniz, L., 2016. Leprosy Among Children Under 15 Years Of Age: Literature Review. Anais Brasileiros De Dermatologia, 91(2), Pp.196-203.
Pinheiro, R., De Souza Salles, J., Sarno, E. And Sampaio, E., 2011. Mycobacterium Leprae–Host-Cell Interactions And Genetic Determinants In Leprosy: An Overview. Future Microbiology, 6(2), Pp.217-230.
Prakoeswa, F., Soebono, H., Husada, D., Notobroto, H., Listiawan, M., Endaryanto, A. And Prakoeswa, C., 2021. Environmental Factors And Leprosy In Mother And Child: A Study In Endemic Areas In East Java, Indonesia. Indian Journal Of Forensic Medicine & Toxicology, 15(2), Pp.2365-2372.
Robertson, J., 2018. Leprosy's Untainted Child. Bulletin Of The History Of Medicine, 92(2), Pp.261-286.
Rosdiana,B. I., Astari,L., Astindari,A., Prakoeswa,C. R. S., Zulkarnain,I., Damayanti,D.,Utomo,B. And Listiawan,M. Y., 2021. The Profile Of Type 1 Leprosy Reaction At Leprosy Division Of Dermatology And Venerology Outpatient Clinic Of Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, Berkala Ilmu Kesehatan Kulit Dan Kelamin, 33(3),Pp.168-172. Doi:10.20473/Bikk.V33.3.2021.168-172.
Ruiz-Fuentes, J., Rumbaut Castillo, R., Hurtado Gascón, L. And Pastrana, F., 2019. Leprosy In Children: A Cuban Experience On Leprosy Control. BMJ Paediatrics Open, 3(1), P.E000500.
Saqib, M., Khatri, R., Singh, B., Gupta, A., Kumar, A. And Bhaskar, S., 2016. Mycobacterium Indicus Pranii As A Booster Vaccine Enhances BCG Induced Immunity And Confers Higher Protection In Animal Models Of Tuberculosis. Tuberculosis, 101, Pp.164-173.
Serrano-Coll, H., Mora, H., Beltrán, J., Duthie, M. And Cardona-Castro, N., 2019. Social And Environmental Conditions Related To Mycobacterium Leprae Infection In Children And Adolescents From Three Leprosy Endemic Regions Of Colombia. BMC Infectious Diseases, 19(1).
Shenoy, M. And Shenoy, S., 2013. Mid-Borderline Leprosy. Indian Dermatology Online Journal, 4(2), P.162.
Smith, D., 2020. Leprosy: Background, Pathophysiology, Epidemiology. [Online] Emedicine.Medscape.Com. Available At: [Accessed 13 December 2021].
World Health Organization, 2018. Guidelines For The Diagnosis, Treatment And Prevention Of Leprosy. [Ebook] New Delhi: World Health Organization, Regional Office For South-East Asia. Available At: [Accessed 12 February 2022].
World Health Organization, 2020. Leprosy/Hansen Disease: Management Of Reactions And Prevention Of Disabilities. Technical Guidance. [Ebook] New Delhi: World Health Organization, Regional Office For South-East Asia. Available At: [Accessed 12 February 2022].
Wulan, I., Agusni, I. And Rosita, C., 2014. PROFIL PASIEN KUSTA BARU PADA ANAK. Berkala Ilmu Kesehatan Kulit Dan Kelamin – Periodical Of Dermatology And Venereology, 26(2), Pp.103-108.. Https://Databoks.Katadata.Co.Id/Datapublish/2021/11/24/Jumlah-Penderita-Diabetes-Di-Indonesia-diproyeksikan-capai-2857-juta-pada-2045.
